期刊
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
卷 34, 期 4, 页码 446-456出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2990.2008.00963.x
关键词
amyloid plaque; Creutzfeldt-Jakob disease; prion; TAR-DNA binding protein-43; ubiquitin; vCreutzfeldt-Jakob disease
资金
- MRC [MC_U123192748] Funding Source: UKRI
- Medical Research Council [MC_U123192748] Funding Source: Medline
- Medical Research Council [MC_U123192748] Funding Source: researchfish
Aims: TAR-DNA binding protein-43 (TDP-43) is the major ubiquitinated protein in the aggregates in frontotemporal dementia with ubiquitin-positive, tau-negative inclusions and motor neurone disease. Abnormal TDP-43 immunoreactivity has also been described in Alzheimer's disease, Lewy body diseases and Guam parkinsonism-dementia complex. We therefore aimed to determine whether there is TDP-43 pathology in human prion diseases, which are characterised by variable deposition of prion protein (PrP) aggregates in the brain as amyloid plaques or more diffuse deposits. Material and methods: TDP-43, ubiquitin and PrP were analysed by immunohistochemistry and double-labelling immunofluorescence, in sporadic, acquired and inherited forms of human prion disease. Results: Most PrP plaques contained ubiquitin, while synaptic PrP deposits were not associated with ubiquitin. No abnormal TDP-43 inclusions were identified in any type of prion disease case, and TDP-43 did not co-localize with ubiquitin-positive PrP plaques or with diffuse PrP aggregates. Conclusions: These data do not support a role for TDP-43 in prion disease pathogenesis and argue that TDP-43 inclusions define a distinct group of neurodegenerative disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据